Anthony Pizzarelli 5/21/25 Anthony Pizzarelli 5/21/25

Psilocybin an effective treatment for repeated concussions, study suggests By Paul McClure April 30, 2025

Anthony Pizzarelli 3/18/25 Anthony Pizzarelli 3/18/25

Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.

Anthony Pizzarelli 3/10/25 Anthony Pizzarelli 3/10/25

Psilocybin, in 10mg or 25mg doses, has no short- or long-term detrimental effects in healthy people by Kings College London

Anthony Pizzarelli 12/23/24 Anthony Pizzarelli 12/23/24

The Johns Hopkins Center for Psychedelic and Consciousness Research is leading the way in exploring innovative treatments using psilocybin.

Anthony Pizzarelli 10/4/24 Anthony Pizzarelli 10/4/24

Psilocybin may be as effective as common antidepressant in treating depression, Written by Jessica Freeborn on August 27, 2024 — Fact checked by Kevin Cyr, MD

Anthony Pizzarelli 8/19/24 Anthony Pizzarelli 8/19/24

Psilocybin found in magic mushrooms shows promise as a treatment for depression Written by Tony Hicks

Anthony Pizzarelli 5/23/24 Anthony Pizzarelli 5/23/24

Can the psychedelic in magic mushrooms treat depression? Ohio State professor weighs in. Written By Max Filby

Anthony Pizzarelli 5/8/24 Anthony Pizzarelli 5/8/24

Psilocybin outperforms other treatments in easing depression in study

Anthony Pizzarelli 1/4/24 Anthony Pizzarelli 1/4/24

CONGRESS IS PUSHING REVOLUTIONARY RESEARCH ON PSYCHEDELIC TREATMENTS FOR THE MILITARY

Anthony Pizzarelli 12/11/23 Anthony Pizzarelli 12/11/23

Therapeutics Announces First Patient Enrolled in FDA-authorized Study Evaluating Low-Dose Psilocybin in Human Subjects with Demoralization by Diamond Therapeutics Inc.

Anthony Pizzarelli 10/18/23 Anthony Pizzarelli 10/18/23

Psychedelic Science: How Microdosing Magic Mushrooms Might Mend the Mind

Anthony Pizzarelli 8/21/23 Anthony Pizzarelli 8/21/23

Psychedelic spurs growth of neural connections lost in depression By Bill Hathaway

Anthony Pizzarelli 8/5/23 Anthony Pizzarelli 8/5/23

FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs by FDA.com

Anthony Pizzarelli 7/28/23 Anthony Pizzarelli 7/28/23

Psilocybin Shows Early Promise for Anorexia Nervosa Megan Brooks July 25, 2023

Anthony Pizzarelli 7/27/23 Anthony Pizzarelli 7/27/23

Psilocybin clinical trails open enrollment at UCSF July 2023

Anthony Pizzarelli 7/19/23 Anthony Pizzarelli 7/19/23

Campaign to decriminalize magic mushrooms in California vies ballot initiative by Morgan Rynor

Anthony Pizzarelli 7/13/23 Anthony Pizzarelli 7/13/23

Berkeley, California Decriminalizes Possession Psilocybin Mushrooms: by Psychedelic Spotlight on July 12, 2023

Anthony Pizzarelli 6/28/23 Anthony Pizzarelli 6/28/23

First modern-era Colorado psilocybin clinical trial for depression set to launch this fall by Katie Mccrimmon UCHEALTH

Anthony Pizzarelli 6/21/23 Anthony Pizzarelli 6/21/23

Psilocybin and Anti Depressants Clinical Trial Information: written by Kristen Monaco, Senior Staff Writer, MedPage May 25, 2023

Anthony Pizzarelli 6/6/23 Anthony Pizzarelli 6/6/23

California Senate Passes SB 518 To Decriminalize Psilocybin Therapeutics: Written by Allen Steiner Lucid News 6/2/23